baber/WOPTO huggingface dataset:
Patent NZ-290907-A (NZ)
Title: Can stack inter-tier dividing panel: tab secured can and corresponding push out rings
Inventor: CAMPBELL GEOFFREY
IPC: B65D71/00
Filed: 1995-08-09
Abstract: PCT No. PCT/GB95/01877 Sec. 371 Date Apr. 25, 1997 Sec. 102(e) Date Apr. 25, 1997 PCT Filed Aug. 9, 1995 PCT Pub. No. WO96/05121 PCT Pub. Date Feb. 22, 1996A paperboard separating sheet (10) for separating two stacked layers of cans (11, 12) is disclosed. The sheet has a plurality of can receiving locations (13), each location having an inner opening (23) and an outer opening (24), respectively, each one of the openings being defined by a series of cuts (23, 24), respectively, in the paperboard sheet. The cuts define first, second, and third covering portions (20, 21, 22), respectively, which are joined together by a plurality of tabs (25, 26), respectively, which allow the respective covering portions to move into different planes relative to one another when the separating sheet is sandwiched between two stacked cans. In use, the third portion of the separating sheets rests on a top rim of a lower can (11), the second portion of the paperboard sheet sits between the top rim of the can and a recessed panel in which a can opening device is formed, and the first portion of the paperboard sheet covers the can opening device. So constructed, the paperboard sheet allows an upper can to rest upon a lower can without metal-to-metal contact between the cans.
Patent NZ-299818-A (NZ)
Title: Slow release nifedipine press-coated tablet containing nifedipine and hydrophilic gel-forming high molecular weight substance core and coating
Inventor: NISHIOKA TAKAAKI
IPC: A61K31/4422
Filed: 1996-11-25
Abstract: This invention provides a long-lasting release solid nifedipine preparation which exhibits clinically sufficient effect when administered once per day. ÄConstructionÜ   A press coated tablet whose core and shell each contains nifedipine, the dissolution rate of nifedipine from said tablet being   (a) in the dissolution test using a sinker according to method 2 of the dissolution test method as prescribed by the Pharmacopoeia of Japan,   after 2 hours   10-40% after 4 hours   30-65% after 6 hours   at least 55%,  and (b) in the dissolution test according to the disintegration test method as prescribed by the Pharmacopoeia of Japan,   after 3 hours   20-45% after 4 hours   30-65%. c
Patent NZ-304867-A (NZ)
Title: Insectides comprising 1-(2,6 dichloro-4-4-trifluoromethyl)phenyl pyrazoles
Inventor: TWINN DAVID CHARLES
IPC: A01N43/56
Filed: 1996-03-27
Abstract: A method of controlling cockroaches and ants or a population of cockroaches or ants with an effective amount of a 1-phenyl-pyrazole derivative applied to a surface, on which the insect is moving or expected to move. The active ingredient is in the form of a thin layer or embedded in a thin layer, which the insect is not able to seize or bite or eat directly. The 1-phenyl-pyrazole derivative has the formula (I) wherein: R1 is cyano; R2 is -S(O)2-R3 group; R3 is alkyl or haloalkyl; R4 is H, halo, -NR5R6 or C(O)O-R7, alkyl, haloalkyl, OR8, -N=C(R9)(R10);  and the rest of the variables are defined in the specification.
Patent NZ-336220-A (NZ)
Title: Endothelin intermediates by asymmetric conjugate addition reaction using a chiral additive
Inventor: TILLYER RICHARD D
IPC: C07D213/85
Filed: 1998-01-09
Abstract: A process for the preparation of a compound of formula I wherein Ring A represents: A) optionally substituted heterocyclyl containing one, two or three double bonds and 1, 2 or 3 heteroatoms selected from O, N and S; B) optionally substituted carbocyclyl containing one or two double bonds; C) optionally substituted phenyl, naphthyl, alkoxy, alkyl, alkenyl, alkynyl, or cycloalkyl, R1 is: A) alkyl, alkenyl, alkynyl, cycloalkyl, B) aryl, or C) optionally substituted heteroaryl; heteroaryl; R2 is OR4 or N(R5)2; R3 is H, alkyl, alkenyl, alkynyl, alkoxyl, cycloalkyl, S(O)tR5, Br, Cl, F, I, aryl,  heteroaryl, N(R5)2, NH2, CHO, -CO-alkyl, -CO-aryl, -CO-heteroaryl, -C02R4, or protected aldehyde; X and Y are independently: O, S, or NR5; n is 0 to 5; t is 0, 1 or 2; R4 is alkyl; and R5 is alkyl, or aryl; comprising reacting an alpha, beta-unsaturated ester or amide of formula (II) with an organolithium compound, R1Li, in the presence of a chiral additive and an aprotic solvent at a temperature range of about -78 C to about 0 C.
Patent NZ-500383-A (NZ)
Title: A hybrid telecommunication system for routing calls
Inventor: ZEY DAVID A
IPC: H04M3/00
Filed: 1998-04-15
Abstract: A hybrid telecommunication system includes a circuit switched network, which transfers information across the Internet to provide multi-routed and multidimensional callback processing. The hybrid network includes one or more circuit switched networks coupled to one or more packet switched networks, and a call router coupled to the switched communication network and the packet switched network to route information to the appropriate switched telephony device or Internet device address. A computer with an attached display communicates with the packet transmission network. The computer is used to initiate remote management of the hybrid network, including tests of the hybrid network. The tests include circuit analysis such as selecting signalling states which could be loop start, ground start, or detecting signals such as dual tone multifrequency, multifrequency or dial pulse. The hybrid network includes support for an operator to monitor the management of the hybrid network, and an expert system to regulate the Quality of Service of the hybrid telecommunication system.
Patent NZ-504443-A (NZ)
Title: Sock with reduced thickness portion on one side from toe to heel
Inventor: PALMER PAUL
IPC: A41B11/00
Filed: 1998-11-20
Abstract: A sock (10) including a foot portion (11) and a leg portion (12), wherein a part of the foot portion (11) along a part of at least one side thereof has a reduced thickness (22) compared with the remainder of the sock (10).
Patent NZ-505590-A (NZ)
Title: Constant-volume dispensing container
Inventor: SUZUKI KENICHI
IPC: B65D47/20
Filed: 1999-01-20
Abstract: A vessel (8) for pouring out and applying a constant amount of liquid, consisting of a bottle, a stopper unit, a switching unit, an operating unit and a valve unit. The stopper unit (1) includes an attaching unit (2), which attaches the stopper unit to the bottle. The switching unit (4) fits tightly onto the attaching unit (2). The operating unit (5) is fixed to the switching unit and includes both a pouring out mouth, at an upper end, and a measuring chamber (A) for delivering a set volume of liquid. The stopper unit (7) is covered by a cap (7).
Patent NZ-505868-A (NZ)
Title: Processing of graphical digital picture data in a decoder
Inventor: HAMERY DOMINIQUE
IPC: G09G5/36
Filed: 1999-02-08
Abstract: A decoder (13) for a digital audiovisual transmission system, the decoder (13) comprising a general processor (20) for decompressing compressed digital picture data and a graphic processor means (36) for preparing the decompressed data for display, characterised in that the general processor (20) is adapted to decompress and store an image file in its substantially original format and subsequently to convert the image file to at least a second format for storage and display, the first and second format versions of the image file being stored contemporaneously in a memory (20) of the decoder.
Patent NZ-506204-A (NZ)
Title: Advanced active devices and methods for molecular biological analysis and diagnostics
Inventor: ACKLEY DONALD E
IPC: B01L3/00
Filed: 1999-02-11
Abstract: An electronic device for performing active biological operations utilize various structures to advantageously collect and provide charged biological materials to an array of microlocations.  The device includes focusing electrodes to aid in the direction and transport of materials from a collection electrode to an array.  Preferably, one or more intermediate transportation electrodes are utilized, most preferably of monotonically decreasing size between the collection electrode and the array, so as to reduce current density mismatches. In another aspect, a flow cell is utilized over devices to provide containment of solution containing materials to be analyzed. In yet another embodiment, a concentric ring design is provided.
Patent NZ-506623-A (NZ)
Title: Acylated betulin and dihydrobetulin derivatives, preparation thereof and use in treatment of retroviral infections
Inventor: LEE KUO-HSIUNG
IPC: A61K31/575
Filed: 1999-03-02
Abstract: A compound of Formula (l) or its salt for use in treating HIV infection, wherein: R1 is a C2-C20 optionally substituted carboxyacyl, R2 is a C2-C20 optionally substituted carboxyacyl; and R3 is hydrogen, halogen, amino, optionally substituted mono-or di-alkylamino, or-OR4; R4 is hydrogen, C1-4 alkanoyl, benzoyl, or C2-C20 optionally substituted carboxyacyl; the dashed line represents an optional double bond between C20 and C29; and provided that when R3 is hydrogen, then R1 and R2 are both succinyl, maleyl, fumaroyl or glutaryl.
Patent NZ-514921-A (NZ)
Title: A grenade
Inventor: SHARPLIN WILLIAM JAMES
IPC: F42B12/56
Filed: 2001-10-18
Abstract: A grenade having a case (1), a sabot (2) and a cover (3), the sabot (2) having a base part, a space for receiving a projectile or projectiles (18), and a plurality of petals (14).  The grenade is formed such that when it is arranged for use the sabot (2) is fitted to the case (1), the projectile or projectiles are within the space, and the cover (3) is fitted around the petals (14).    The end parts of the petal (14) bend towards one another to substantially encapsulate the projectile or projectiles (18).  The grenade is formed such that when it is in use and is fired from a suitable rifle a charge in the case (1) causes the sabot (2) and the projectile or projectiles (18) to be propelled forward and punch through the cover (3) such that the projectile or projectiles (18) are released from the sabot (2) to a target.
Patent NZ-515424-A (NZ)
Title: Hemisynthetic method and new compounds
Inventor: CHICHARRO JOSE LUIS
IPC: A61P35/00
Filed: 2000-05-15
Abstract: Methods for preparing a compound with a fused ring structure of formula (XVIIc) are disclosed, which comprises one or more reactions starting from a 21-cyano compound of formula (XVIb), in modified starting materials, the 21-cyano group can be replaced by other groups introduced using nucleophilic reagents, wherein the variables shown in formula (XVIIc) and formula (XVIb) are as defined in the specification.
Patent NZ-517270-A (NZ)
Title: Nested duckbill check valves
Inventor: JAWORSKI THOMAS
IPC: F16K15/14
Filed: 2000-09-08
Abstract: A check valve assembly, comprising: (a)  A first duckbilled check valve having an inlet at one end, an elastomeric bill formed at an opposite end, and a neck there between, the bill having opposed lips and an outlet openable by a flexing of the lips apart; (b)  Wherein the bill of the first duckbill check valve is telescoped into and retained in the inlet of the second duckbill check valve with the lips of the first valve able to move outward inside the inlet of the second valve; and (c)  Wherein the bill of the first duckbill check valve is held in a nested together configuration with the inlet of the second duckbilled check valve by a snap fit connection between the neck of the first duckbilled check valve and the inlet of the second duckbilled check valve.
Patent NZ-523390-A (NZ)
Title: Biological control of crown gall disease using an alpha proteobacteria strain i.e. Agrobacterium that can roduce trifolitoxin
Inventor: TRIPLETT ERIC W
IPC: A01N63/00
Filed: 2001-08-10
Abstract: A method for controlling crown gall disease on plants comprises introducing onto the plant an effective amount of a biologically pure culture of an alpha-proteobacteria strain that produces trifolitoxin. Preferably the strain of alpha-proteobacteria is Agrobacterium bacteria.
Patent NZ-526222-A (NZ)
Title: Layered catalyst composition having an outer refractory inorganic oxide layer and processes for preparing and using the composition
Inventor: JENSEN ROBERT
IPC: C07C15/107
Filed: 2000-11-27
Abstract: A layered catalyst composition and a process for preparing the composition and processes for using the composition are disclosed, wherein the catalyst composition comprises an inner core such as alpha-alumina, and an outer layer bonded to the inner core composed of an outer refractory inorganic oxide such as gamma-alumina, the outer layer optionally has uniformly dispersed thereon a platinum group metal such as platinum and a promoter metal such as tin, the composition also optionally contains a modifier metal such as lithium. This catalyst composition shows durability and selectively for dehydrogenating hydrocarbons.
Patent NZ-528654-A (NZ)
Title: Coating for a flexible fluid containment vessel and a method of making the same
Inventor: ROMANSKI ERIC
IPC: D03D3/02
Filed: 2002-04-05
Abstract: A flexible fluid containment vessel fabricated out of fabric for transporting and containing a large volume of fluid, particularly fresh water, with the fabric being made from coated thermoplastic yarns or fiber such that its respective sides have coatings so formed thereon that are different from each other or the fabric is coated with voids such that its overall density of the coated fabric is less than 1 g/cm<3> allowing it to float.
Patent NZ-530227-A (NZ)
Title: Enhanced drug delivery in transdermal systems
Inventor: HOUZE DAVID
IPC: A61K47/48
Filed: 2002-06-18
Abstract: Disclosed are compositions for the transdermal delivery of drugs, comprising a therapeutically effective amount of a drug that includes a parent drug and a prodrug, wherein (a) the parent drug is selected from ACE inhibitors, anabolic steroids, androgenic steroids, glucocorticoids, mineral corticoids, progestins, and estrogens, or (b) the parent drug is estradiol and the prodrug is an estradiol derivative. Also disclosed is a method of suppressing crystal formation of a steroid in a transdermal drug delivery system, comprising combining two or more corresponding derivatives of the steroid in a pressure-sensitive adhesive carrier composition.
Patent NZ-533094-A (NZ)
Title: Phospholipid derivatives of nucleosides as antitumoral medicaments
Inventor: HERRMANN DIETER
IPC: C07H19/10
Filed: 2002-11-18
Abstract: Phospholipid derivatives, preferably of non-natural nucleosides, of formula (I) in which, R1 represents dodecyl; R2 represents decyl; n represents an integer equal to 0, 1 or 2; R3 represents a hydroxy group; R4 and R5 represent hydrogen; and B represents 5-fluorouracil; their physiologically tolerable salts, stereoisomers or tautomers as well as all optically active forms and enantiomer mixtures.
Patent NZ-534726-A (NZ)
Title: Method for treating cognitive disorders usch as Alzheimer's disease using (+)9-N-phenylcarbinol esroline the (+) isomer of phenserine
Inventor: GREIG NIGEL
IPC: A61K31/407
Filed: 2003-03-18
Abstract: A pharmaceutical composition comprises the compound of formula (II) the (+) phenserine enantiomer. The composition is useful for treating patients having a disease state exhibiting cognitive impairments associated with aging or Alzheimer's disease.
Patent NZ-537909-A (NZ)
Title: Radome illumination system
Inventor: KORTE DONALD RANDOLPH
Filed: 2005-01-25
Abstract: A radar system is disclosed which includes (a) an antenna system (1) which in use, transmits radio frequency energy and receives radar echo signals in multiple directions within multiple sectors, (b) a radar controller which energises the antenna to transmit radar signals in selected directions in the sectors, (c) a visual illumination system associated with the antenna system (1) and which includes in at least one sector an energisable visual indicator (6), and (d) a visual interface circuit (14) which receives a signal from said radar controller to energise the visual indicator (6) in a sector when the antenna (1) transmits a radar signal in the sector.
Patent NZ-538246-A (NZ)
Title: Component for governing air flow in and around cylinder head port
Inventor: BONDE KEVIN G
IPC: F02M35/10
Filed: 2003-07-17
Abstract: A cylinder head assembly and a method of providing an air-fuel mixture from a carburettor to a cylinder of an internal combustion engine are disclosed. The cylinder head assembly includes a cylinder head and a component coupled to the cylinder head. The cylinder head includes a first port having a first passage linking a first end to an intersection, and a second passage linking a second end to the intersection, where the intersection includes an abrupt transition between the first and second passages. The component includes a tongue that protrudes into the first passage from the first end to proximate the intersection, where the tongue is positioned along at least a portion of an inner side of the first passage, and where the tongue is gradually-reduced in thickness at least proximate the intersection.
Patent NZ-542369-A (NZ)
Title: Roof support system and installation method
Inventor: CROWLEY DARREN STUART
Filed: 2005-09-14
Abstract: A method of installing a pair of cut triangular tiles and a starter ridge tile includes fixing an L or V-shaped support device 1 to the roof, positioning the pair of cut triangular tiles on a support surface of the support device 1, locating a first amount of cement on the cut tiles and positioning a starter ridge tile on the cement.
Patent NZ-542671-A (NZ)
Title: 7-Amido-isoindolyl compounds and their pharmaceutical uses
Inventor: MAN HON-WAH
IPC: C07D217/22
Filed: 2004-03-12
Abstract: Disclosed is a compound of formula (II) wherein the substituents are disclosed within the specification or a pharmaceutically acceptable salt or solvate thereof. Also disclosed is the use of the above compound in the preparation of a composition for inhibiting PDE4 in a mammal, for modulating the production of TNF-alpha in a mammal or for inhibiting MMP in a mammal.
Patent NZ-542935-A (NZ)
Title: Recombinant influenza viruses holding a mutation in a transmembrane protein gene
Inventor: KAWAOKA YOSHIHIRO
IPC: C12N7/00
Filed: 2004-04-20
Abstract: Disclosed is an isolated recombinant influenza virus comprising a mutant integral membrane protein gene which does not encode a functional integral membrane protein or a functional portion thereof, wherein the mutant integral membrane protein gene comprises at least two mutations relative to a corresponding integral membrane protein gene which encodes a functional integral membrane protein, one of which mutations is not in a region of the integral membrane protein gene corresponding to the transmembrane domain, wherein the integral membrane protein is the M2 protein of influenza A virus or the NB protein of influenza B virus. Also disclosed is a method of making said virus and a composition thereof.
Patent NZ-550010-A (NZ)
Title: 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride in crystalline form and the process for its preparation
Inventor: PIVETTI FAUSTO
IPC: A61K31/47
Filed: 2005-03-24
Abstract: Disclosed is a process for the preparation of 8-hydroxy-5-[(1R)1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1 H)-quinolinone mono-hydrochloride (I) comprising crystallising or re-crystallising compound (I) from an ethanol-water mixture in a ratio from 97:3 to 95:5 added with diisopropyl ether, wherein the ethanol-water mixture is concentrated under reduced pressure at a temperature comprised between 30 and 55 Deg. C to a volume comprised between 1/2 and 1/3 of the initial volume and the addition of the diisopropyl ether is performed in at least 5 minutes.
Patent NZ-551191-A (NZ)
Title: Hand cart for storing and transporting household refuse and the like
Inventor: BRUMBY GRANT JOHN
Filed: 2006-11-08
Abstract: Disclosed is an antibacterial compound adapted for use against bacteria which produce urease or nitrogenase enzymes, comprising a mixture including phytic acid and honey (particularly manuka honey,), wherein the proportion of phytic acid to honey is between 1:999 and 1:99, wherein the proportion of phytic acid to honey is between 1:999 and 1:99, whereby in use said phytic acid is in sufficient proportion relative to said honey to facilitate antibacterial action of said honey by neutralizing ammonia produced by said enzymes, without leaving residual phytic acid sufficient to cause a significant antinutrient effect.
Patent NZ-563432-A (NZ)
Title: T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
Inventor: ZEIS MATTHIAS
IPC: A61K39/00
Filed: 2006-04-26
Abstract: Provided is a tumour associated peptide of 10 amino acids consisting of the sequence Leu Leu Ala Ala Arg Ala Ile VaI Ala Ile. The peptide has the ability to bind to a molecule of the human major histocompatibility complex (MHC) class-I, in particular to HLA-A* 0201 and is capable of eliciting the production of a cytotoxic T lymphocyte (CTL) which recognizes a cell which expresses a polypeptide comprising the said polypeptide. The peptide can be used in a cancer vaccine and in the production of activated CTLs.
Patent NZ-566513-A (NZ)
Title: Prefabricated transparent film drawn from canister across lens and suitable for goggles for motorcross
Inventor: GILL JASON GREGORY
Filed: 2008-03-07
Abstract: Disclosed is a apparatus for moving a transparent film across a permanent lens consisting of a transparent film perforated at predetermined intervals along its length, a canister for holding the transparent film and adapted for placement at one side of the lens, and a film engagement means for engaging a free end of the film and adapted for placement on an opposite side of the lens. The film is thereby allowed to extend across the lens and is partially supported in position by lying flush against the permanent lens.
Patent NZ-572226-A (NZ)
Title: Pre-mixed, ready-to-use IV bolus compositions comprising nicardipine and methods of use
Inventor: GUPTA SUPRIYA
IPC: A01N43/40
Filed: 2007-04-18
Abstract: Disclosed is a pharmaceutical composition comprising a pharmaceutically acceptable salt of nicardipine in an aqueous carrier, a cyclodextrin, one or more buffering agents, and having a pH within the range from about 3.5 to about 5.5; wherein the concentration of the nicardipine in the composition is 0.25-5.0 mg/ml inclusive, the concentration of each buffering agent in the composition is 0.1-100 mM, and wherein the composition is formulated for direct parenteral bolus administration to a human. Also disclosed is the use of the above composition to treat elevated blood pressure by parental administration.
Patent NZ-576372-A (NZ)
Title: Native (telopeptide) placental collagen compositions
Inventor: BHATIA MOHIT
IPC: A61P17/02
Filed: 2007-10-09
Abstract: Disclosed is a composition comprising base-treated, detergent treated Type I telopeptide placental collagen, wherein said collagen has not been chemically modified or treated with a protease. Further disclosed is a method of making a composition comprising telopeptide collagen, comprising, in order, the steps of: (a) macerating placental tissue; (b) suspending the placental tissue in a hypertonic saline solution; and (c) treating the placental tissue with a mild detergent, wherein said collagen has not been chemically modified or treated with a protease.